Literature DB >> 33469104

The effect of anxiety and depression on progression of glaucoma.

Da Young Shin1, Kyoung In Jung1, Hae Young Lopilly Park1, Chan Kee Park2.   

Abstract

Glaucoma is considered a chronic disease that requires lifelong management. Chronic diseases are known to be highly associated with psychological disturbances such as depression and anxiety. There have also been many studies on association between anxiety or depression and glaucoma. The majority of these studies explained that the glaucoma diagnosis causes anxiety or depression. However, It is also necessary to evaluate whether the psychological disturbance itself affect glaucoma. Therefore, we investigated the association of anxiety and depression with glaucoma progression, and elucidate mechanisms underlying that. We included 251 eyes with open angle glaucoma who were followed up for at least 2 years in this retrospective case-control study. The Beck Anxiety Inventory (BAI) and Beck Depressive Inventory-II (BDI-II) were used to assess anxiety and depression in glaucoma patients. Patients were classified into groups (high-anxiety group; HA-G, low-anxiety group; LA-G, high-depression group; HD-G, low-depression group; LD-G) according to their score on the BAI or BDI-II (separately). In logistic regression analysis, disc hemorrhage, peak intraocular pressure (IOP) and RNFL thickness loss rate were significantly associated with high anxiety (p = 0.017, p = 0.046, p = 0.026). RNFL thinning rate and disc hemorrhage were significant factors associated with anxiety in multivariate models (p = 0.015, p = 0.019). Multivariate linear regression analysis showed a significant positive correlation between the rate of RNFL thickness loss and BAI score (B = 0.058; 95% confidential interval = 0.020-0.097; p = 0.003), and RNFL loss and IOP fluctuation (B = 0.092; 95% confidential interval = 0.030-0.154; p = 0.004). For the depression scale, visual field mean deviation and heart rate variability were significantly associated with high depression in multivariate logistic regression analysis (p = 0.003, p = 0.006). We suggest that anxiety increase the risk of glaucoma progression and they are also associated with IOP profile and disc hemorrhage.

Entities:  

Year:  2021        PMID: 33469104      PMCID: PMC7815884          DOI: 10.1038/s41598-021-81512-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  42 in total

1.  The pathology of the pituitary and adrenal glands in systemic disease in man.

Authors:  A R CURRIE; T SYMINGTON
Journal:  Proc R Soc Med       Date:  1955-11

2.  Properties of the statpac visual field index.

Authors:  Paul H Artes; Neil O'Leary; Donna M Hutchison; Lisa Heckler; Glen P Sharpe; Marcelo T Nicolela; Balwantray C Chauhan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-08       Impact factor: 4.799

3.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

Review 4.  The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.

Authors:  Elizabeth I Martin; Kerry J Ressler; Elisabeth Binder; Charles B Nemeroff
Journal:  Clin Lab Med       Date:  2010-12       Impact factor: 1.935

5.  The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma.

Authors:  Y Yamazaki; S M Drance
Journal:  Am J Ophthalmol       Date:  1997-09       Impact factor: 5.258

6.  Can Psychologic Stress Elevate Intraocular Pressure in Healthy Individuals?

Authors:  Ricardo Y Abe; Thairis C Silva; Izabella Dantas; Sebastião X Curado; Mariana S Madeira; Luciene B de Sousa; Vital P Costa
Journal:  Ophthalmol Glaucoma       Date:  2020-07-03

7.  Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field.

Authors:  Xinbo Zhang; Anna Dastiridou; Brian A Francis; Ou Tan; Rohit Varma; David S Greenfield; Joel S Schuman; David Huang
Journal:  Am J Ophthalmol       Date:  2017-09-28       Impact factor: 5.258

Review 8.  Experiences of patient-centredness with specialized community-based care: a systematic review and qualitative meta-synthesis.

Authors:  S Winsor; A Smith; M Vanstone; M Giacomini; F K Brundisini; D DeJean
Journal:  Ont Health Technol Assess Ser       Date:  2013-09-01

9.  Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study.

Authors:  J Rezapour; S Nickels; A K Schuster; M Michal; T Münzel; P S Wild; I Schmidtmann; K Lackner; A Schulz; N Pfeiffer; M E Beutel
Journal:  BMC Ophthalmol       Date:  2018-06-28       Impact factor: 2.209

10.  Association between peripapillary scleral deformation and choroidal microvascular circulation in glaucoma.

Authors:  Da Young Shin; Soo Ji Jeon; Eun Kyoung Kim; Kyoung In Jung; Hae Young Lopilly Park; Chan Kee Park
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

View more
  9 in total

1.  Anatomical Evidence for the Neural Connection from the Emotional Brain to Autonomic Innervation in the Anterior Chamber Structures of the Eye.

Authors:  Lin Ma; Fang Yang; Qing Liu; Xu-Tao Zhu; Xin Liu; Sen Jin; Hua-Dong Wang; Lei Pei; Fu-Qiang Xu; Hai-Xia Liu
Journal:  Curr Med Sci       Date:  2022-04-02

Review 2.  Patient-centred care in ophthalmology: current practices, effectiveness and challenges.

Authors:  Shing Chuen Chow; Pun Yuet Lam; Bonnie Nga Kwan Choy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-21       Impact factor: 3.535

3.  Effects of non-pharmacological interventions on anxiety, depression, and sleep quality in patients with postoperative glaucoma: A protocol for systematic review and network meta-analysis.

Authors:  Jiong Liu; Lei Cao; Guang Yang; Runhai Zhou
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

4.  Ocular and Hemodynamic Factors Contributing to the Central Visual Function in Glaucoma Patients With Myopia.

Authors:  Kyung Euy Hong; Seong Ah Kim; Da-Young Shin; Chan Kee Park; Hae-Young Lopilly Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

5.  Dual Orexin Receptor Antagonist Attenuates Increases in IOP, ICP, and Translaminar Pressure Difference After Stimulation of the Hypothalamus in Rats.

Authors:  Arthur A DeCarlo; Nathan Hammes; Philip L Johnson; Anantha Shekhar; Brian C Samuels
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

6.  Real-Time Monitoring of Intraocular Pressure in Glaucoma Patients Using Wearable Mobile Medicine Devices.

Authors:  Xiangwen Yuan; Jiabin Zhang
Journal:  J Healthc Eng       Date:  2022-03-28       Impact factor: 2.682

7.  The Effect of Autonomic Nervous System Dysfunction on the Progression of Primary Open-Angle Glaucoma.

Authors:  Binbin Liu; Yin Zhao; Hong Zhang
Journal:  Int J Gen Med       Date:  2022-05-02

8.  The prevalence of anxiety symptoms and disorders among ophthalmic disease patients.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Nadia Artha Dewi; Lely Retno Wulandari
Journal:  Ther Adv Ophthalmol       Date:  2022-04-19

9.  Reduced brain subcortical volumes in patients with glaucoma: a pilot neuroimaging study using the region-of-interest-based approach.

Authors:  Jaelim Cho; Changsoo Kim; Yae Won Ha; Heeseon Jang; Sang-Baek Koh; Young Noh; Seung-Koo Lee; Sang Won Seo
Journal:  BMC Neurol       Date:  2022-07-25       Impact factor: 2.903

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.